Fecula Biotech Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. Development of novel drugs for gut microbiota-based cancer adjuvant therapy
2. Development of probiotic-related health foods
3. Application of utilizable agricultural resources in health foods
2. Development of probiotic-related health foods
3. Application of utilizable agricultural resources in health foods
The content above was translated by Ai
Founded Year
2019
Unified Business No.
42932624
Status
Active
Number of Employees
7
Total Paid-in
Capital
45,035,695 (NT$)
Location of Company
Taiwan
, Tainan City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We focuses on the development and reuse of agricultural and fishery waste, integrating the concepts of sustainability and circular economy. By leveraging biotechnology, we achieve a synergistic effect where 1+1 > 2.
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
The content above was translated by Ai
Corporate Video
